BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Leukocyte
,
Laryngoscope
,
Valproic acid
,
rs3825942
,
CYP51
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cc 3
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Ribosomal protein S18 acetyltransferase RimI is responsible for the acetylation of elongation factor…
Cell surface-associated protein elongation factor Tu interacts with fibronectin mediating the adhesi…
Kinetic Analysis Suggests Evolution of Ribosome Specificity in Modern Elongation Factor-Tus from "Ge…
Molecular evolutionary and 3D protein structural analyses of Lactobacillus fermentum elongation fact…
CSF Levels of Elongation Factor Tu Is Associated With Increased Mortality in Malawian Adults With St…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
SI + CC Versus 3:1 C:V Ratio During Neonatal CPR
Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Fol…
A Phase 2 Study With CC-220 in Skin Sarcoidosis
2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-…
A Rollover Study of CC-122
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ